Have a Claim?

Click here for a confidential contact or call:


September 14, 2016

Posted  September 20, 2016

Healthmark Investment Trust, partial owner of Florida-based compound pharmacy QMedRx, agreed to pay $7.75 million to resolve allegations QMedRx violated the False Claims Act by billing the federal healthcare programs for prescriptions tainted within the meaning of the Anti-Kickback Statute.  The government is still pursuing penalties and fines from other owners and participants within QMedRx.  DOJ (MDFL)

Tagged in: Anti-Kickback and Stark, Compounding Pharmacy Fraud, FCA Federal, Other Government Health Programs,